Aggregate Report Writing in Pharmacovigilance introduces the advanced knowledge and applied strategies needed to plan, write, and review aggregate safety reports for medicinal products. This course explains how reports such as PSURs, PBRERs, and DSURs support ongoing pharmacovigilance by bringing together safety data over time and helping regulators assess whether a medicine’s benefits continue to outweigh its risks.
You will gain a practical understanding of the foundations of aggregate reporting, the differences between major report types, benefit–risk evaluation methods, regulatory submission planning, and cross-functional coordination. The course explores regional regulatory expectations, data cut-off dates and database lock points, consistency across periodic reports, quality control, and how signal detection findings and regulatory feedback are incorporated into future reporting cycles.
The course focuses on key aspects of aggregate reporting in practice, including:
• The purpose and structure of PSURs, PBRERs, and DSURs
• How to perform and present a structured benefit–risk evaluation
• How to plan submission timelines and coordinate multi-region reporting activities
• How to apply quality control and respond to regulatory feedback in aggregate reporting workflows
Through structured explanations and practical examples, this course helps you understand how high-quality aggregate reports support compliance, transparency, and ongoing benefit–risk evaluation in pharmacovigilance. It is best suited to professionals working in pharmacovigilance, medical writing, regulatory affairs, or related roles who want to strengthen their skills in advanced aggregate reporting.